Prelude Therapeutics
PRLD
#9034
Rank
โ‚น5.87 B
Marketcap
โ‚น106.78
Share price
5.83%
Change (1 day)
-56.47%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -โ‚น179.02

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น182.44. In 2022 the company made an earnings per share (EPS) of -โ‚น205.14 a decrease over its 2021 EPS that were of -โ‚น203.46.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น179.02-12.73%
2022-โ‚น205.140.83%
2021-โ‚น203.46-61.3%
2020-โ‚น525.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น183.28 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA